Andrei S. Gudymo

A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)

M. P. Bogryantseva, Svetlana Usova, Oleg V. Pyankov et al. · Russian Journal of Infection and Immunity · 2021 · 109 citations · Full text

Immunodeficiencies, Peptide-based Epivaccorona Vaccine, Immunology +21

Isolation and characterization of H5Nx highly pathogenic avian influenza viruses of clade 2.3.4.4 in Russia

V. Yu. Marchenko, Ivan M. Susloparov, Natalia Kolosova et al. · Virology · 2018 · 40 citations

Viral Evolution, Emergent Virus, Virology +5

Immunogenicity and protectivity of the peptide vaccine against SARS-CoV-2

M. P. Bogryantseva, Oleg V. Pyankov, Olga G. Pyankova et al. · Annals of the Russian academy of medical sciences · 2021 · 35 citations · Full text

Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)

Evgeny A. Ryzhikov, M. P. Bogryantseva, S. V. Usova et al. · Vaccines · 2023 · 18 citations · Full text

Epivaccorona Peptide Vaccine, Covid-19 Epidemiology, Covid-19 +18

Severe cases of seasonal influenza in Russia in 2017-2018

Natalia Kolosova, T. N. Ilyicheva, Alexey V. Danilenko et al. · PLoS ONE · 2019 · 17 citations · Full text

Vaccination, Viral Diagnostics, Emerging Infectious Diseases +15